These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 24590287)

  • 41. BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization.
    Li M; Armelloni S; Zennaro C; Wei C; Corbelli A; Ikehata M; Berra S; Giardino L; Mattinzoli D; Watanabe S; Agostoni C; Edefonti A; Reiser J; Messa P; Rastaldi MP
    J Pathol; 2015 Apr; 235(5):731-44. PubMed ID: 25408545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
    Sakairi T; Abe Y; Kopp JB
    Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
    Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure.
    Iwata W; Unoki-Kubota H; Kato H; Shimizu A; Matsumoto M; Imasawa T; Igarashi A; Matsumoto K; Noda T; Terauchi Y; Nangaku M; Kasuga M; Kaburagi Y
    PLoS One; 2020; 15(3):e0229397. PubMed ID: 32191726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
    Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
    Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
    Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
    Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibiting calpain 1 and 2 in cyclin G associated kinase-knockout mice mitigates podocyte injury.
    Tian X; Inoue K; Zhang Y; Wang Y; Sperati CJ; Pedigo CE; Zhao T; Yan M; Groener M; Moledina DG; Ebenezer K; Li W; Zhang Z; Liebermann DA; Greene L; Greer P; Parikh CR; Ishibe S
    JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33208557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
    Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
    Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury.
    Feng Y; Sun Z; Fu J; Zhong F; Zhang W; Wei C; Chen A; Liu BC; He JC; Lee K
    Kidney Int; 2024 Jul; 106(1):50-66. PubMed ID: 38697478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
    Boucher I; Yu W; Beaudry S; Negoro H; Tran M; Pollak MR; Henderson JM; Denker BM
    Lab Invest; 2012 May; 92(5):662-75. PubMed ID: 22249312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.
    Guo J; Ananthakrishnan R; Qu W; Lu Y; Reiniger N; Zeng S; Ma W; Rosario R; Yan SF; Ramasamy R; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2008 May; 19(5):961-72. PubMed ID: 18256352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
    Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.
    Angeletti A; Cantarelli C; Petrosyan A; Andrighetto S; Budge K; D'Agati VD; Hartzell S; Malvi D; Donadei C; Thurman JM; Galešić-Ljubanović D; He JC; Xiao W; Campbell KN; Wong J; Fischman C; Manrique J; Zaza G; Fiaccadori E; La Manna G; Fribourg M; Leventhal J; Da Sacco S; Perin L; Heeger PS; Cravedi P
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32717081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
    J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.